未找到相关数据
Results from a randomized phase III trial of decitabine versus supportive care or low-dose cytarabine for the treatment of older patients with newly diagnosed AML
被引：20
作者：
Thomas, X. G.
Dmoszynska, A.
Wierzbowska, A.
Kuliczkowski, K.
Mayer, J.
Shelekhova, T.
Gau, J.
Chou, W.
Buckstein, R.
Cermak, J.
Kuo, C.
Rocafiguera, A. O.
Koza, V.
Ravandi, F.
Kantarjian, H.
机构：
[1] Hosp Edouard Herriot, Lyon, France
[2] Med Univ Lublin, Lublin, Poland
[3] Coprnicus Mem Hosp, Lodz, Poland
[4] Katedra & Klin Hematol, Wroclaw, Poland
[5] Univ Hosp Brno, Brno, Czech Republic
[6] Clin Profess Pathol & Hematol, Saratov, Russia
[7] Taipei Vet Gen Hosp, Taipei, Taiwan
[8] Natl Taiwan Univ Hosp, Taipei, Taiwan
[9] Odette Canc Ctr, Toronto, ON, Canada
[10] Inst Hematol & Blood Transfus, CR-12820 Prague, Czech Republic
[11] Chang Gung Univ, Coll Med, Div Oncol, Kaohsiung, Taiwan
[12] Hosp Badalona Germans Trias & Pujol, Cataluna, Spain
[13] Univ Hosp, Plzen, Czech Republic
[14] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
关键词：
D O I：
10.1200/jco.2011.29.15_suppl.6504
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
6504
引用
收藏
页数：1
相关论文